| Filed | Form | Description | |
|---|---|---|---|
| 4/29/25 | DEFA14A | DEFA14A | → |
| 4/29/25 | DEF 14A | DEF 14A | → |
| 5/30/24 | DEFA14A | DEFA14A | → |
| 4/29/24 | DEFA14A | DEFA14A | → |
| 4/29/24 | DEF 14A | DEF 14A | → |
| 6/7/23 | DEFA14A | DEFA14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 2/23/26 | 4 | 4 | → |
| 2/4/26 | 4 | 4 | → |
| 2/4/26 | 4 | 4 | → |
| 1/21/26 | 4 | 4 | → |
| 1/21/26 | 4 | 4 | → |
| 1/21/26 | 4 | 4 | → |
| ↓ | |||
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.